ontilyv
bial portela & companhia s.a. - opicapone - parkinsons sygdom - anti-parkinson-lægemidler - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
madopar 100+25 mg kapsler, hårde
orifarm a/s - benserazidhydrochlorid, levodopa - kapsler, hårde - 100+25 mg
madopar "125" 100+25 mg kapsler, hårde
roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - kapsler, hårde - 100+25 mg
madopar "125" 100+25 mg tabletter
roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - tabletter - 100+25 mg
madopar 125 100+25 mg kapsler, hårde
2care4 aps - benserazidhydrochlorid, levodopa - kapsler, hårde - 100+25 mg
madopar 125 100+25 mg tabletter
orifarm a/s - benserazidhydrochlorid, levodopa - tabletter - 100+25 mg
madopar "250" 200+50 mg kapsler, hårde
roche a/s - benserazidhydrochlorid, levodopa - kapsler, hårde - 200+50 mg
madopar "62,5" 50 + 12,5 mg kapsler, hårde
roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - kapsler, hårde - 50 + 12,5 mg
madopar depot 100+25 mg depotkapsler, hårde
roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - depotkapsler, hårde - 100+25 mg
madopar depot 100+25 mg depotkapsler, hårde
orifarm a/s - benserazidhydrochlorid, levodopa - depotkapsler, hårde - 100+25 mg